Competitive Intelligence and Opportunity Assessment

We turn complex scientific, clinical, and commercial information into clear strategic conclusions. Our analyses are designed to support real decisions, not simply describe the competitive landscape.

We integrate information across discovery programs, clinical trials, patents, transactions, scientific publications, and company communications to identify emerging competitors, development risks, opportunities for differentiation, and areas of unmet need.

Our support includes:

• Competitive landscape mapping

• Pipeline, target, and modality analysis

• Clinical efficacy and safety benchmarking

• Patent and intellectual property landscape review

• Deal, financing, and partnership tracking

• Opportunity and threat analysis

• White-space and differentiation assessment

Relevant experience

Fulgurite has conducted detailed competitive assessments across small molecules, peptides, macrocycles, radioligand therapies, biologics and other emerging therapeutic modalities. These projects have supported target selection, portfolio planning, licensing strategy, clinical positioning, and product differentiation.

Our work combines scientific depth with an understanding of how competitive evidence affects development strategy and the future value of an asset.